NCT03148769已完成不适用
Spanish Cohort of Bacteriemias 2016: Epidemiology, Clinical Management and Prognostic Factors at Diagnosis.
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla29 个研究点 分布在 1 个国家目标入组 5,320 人开始时间: 2016年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,320
- 试验地点
- 29
- 主要终点
- Epidemiology and prognostic factors of bacteremia episodes.
研究概览
简要总结
Bacteremia
The Hypothesis of the study are the followings:
- To demonstrate relevant epidemiologic and clinical changes with potentially impact in the management and prognosis of the patients with bacteremia.
- Since the diagnosis and management is heterogeneous between centers, we could identify a scenario to improve.
- To identify quality indicators in the management of bacteremia.
- To demonstrate that some interventions made by Bacteremia Team pose relevant impact in the prognosis of bacteremia.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Every episode of bacteremia in patients older than 13 years old, confirmed microbiologically and clinically significant (presence of clinical sepsis data at diagnosis) should be prospectively included on the basis of standard criteria.
- •Episodes of transient bacteremia may be included.
- •Drugs will be prescribed in the usual way, according to the conditions established in the authorization. The assignment of a patient to a particular therapeutic strategy will not be decided in advance by the study protocol, but will be determined by the usual clinical practice, and the decision to prescribe a particular drug will be clearly dissociated from the decision to include to the patient in the study.
排除标准
- •Bacteremias without clinical relevance
结局指标
主要结局
Epidemiology and prognostic factors of bacteremia episodes.
时间窗: From day 0 to day 30
* Global incidence and per type of acquisition. * Global etiology and per type of acquisition. * Frequency of multiresistant and emerging microorganism. * Source of bacteremia. * Clinical severity of presentation. * Clinical failure, mortality at day 7, mortality at day 30, recurrence, length of stay and re-admission at hospital.
次要结局
- Clinical management of patients with bacteremia during the episode.(From day 0 to day 30)
- Differences in the management between types of services, wards and hospitals.(From day 0 to day 30)
- Influence of clinical management in the prognosis.(From day 0 to day 30)
- Developing and validating a predictive model for early and late mortality.(From day 0 to day 30)
- Quality indicators in the management of bacteremia.(From day 0 to day 30)
- Interventions made by Bacteremia Team.(From day 0 to day 30)
研究者
研究点 (29)
Loading locations...
相似试验
已完成
不适用
Bacterial Epidemiology and Empirical Antibiotherapy in Patients With Prosthetic Joint InfectionJoint InfectionNCT03191292Hospices Civils de Lyon567
撤回
不适用
Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian ChildrenInfections, StreptococcalNCT01160055GlaxoSmithKline
已完成
不适用
Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic HyperplasiaBacteriuria in Symptomatic Benign Prostate HyperplasiaAntibiotic Susceptibility in Symptomatic Benign Prostate HyperplasiaTreatment Response to Antibiotics in Symptomatic Benign Prostate HyperplasiaNCT06520267Tribhuvan University Teaching Hospital, Institute Of Medicine.131
已完成
不适用
Prospective Population Study on Candidemia in SpainFungemiaNCT01236261Fundacion SEIMC-GESIDA730
已完成
不适用
Infective Keratitis in Minia GovernateInfective KeratitisNCT04894630Minia University150